Andere talen BioMarin Pharmaceutical Inc.

Aandelen

BMRN

US09061G1013

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
80,91 ^USD	-1,53%		-8,71%	-16,09%

26/04	BIOMARIN PHARMACEUTICAL INC. : Scotiabank herhaalt Neutraal advies	ZM
25/04	BIOMARIN PHARMACEUTICAL INC. : Wells Fargo Securities nog altijd een koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BioMarin Pharmaceutical Q1 Non-GAAP EPS, Revenue Increase -- Shares Down After Hours	24/04
BioMarin: Q1 Earnings Snapshot	24/04
(BMRN) BIOMARIN PHARMACEUTICAL Forecasts Fiscal Year 2024 EPS Range $2.75 - $2.95	24/04
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 Revenue $648.8M	24/04
Earnings Flash (BMRN) BIOMARIN PHARMACEUTICAL Posts Q1 EPS $0.71	24/04
BioMarin Pharmaceutical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04
BioMarin Reports Record Financial Results for the First Quarter 2024	24/04
BioMarin Pharmaceutical : IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE - Form 8-K	23/04
BioMarin Pharmaceutical Investors to Focus Q1 on Strategic Review, Cost-Cutting Measures, UBS Says	22/04
Biomarin Pharmaceutical Insider Sold Shares Worth $3,645,000, According to a Recent SEC Filing	15/04
BioMarin to Host First Quarter 2024 Financial Results Conference Call and Webcast on Wednesday, April 24, 2024, at 4:30pm ET	10/04
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing	01/04
New Data to be presented for BioMarin's VOXZOGO in Children with Hypochondroplasia and Achondroplasia at the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting	13/03
BioMarin Pharmaceutical Says Voxzogo Leads to Height Gains in Children With Achondroplasia	12/03
ETF der Woche: Auf die Wende der Biotechs setzen	10/03
L'ETF della settimana: scommettere sull'inversione di tendenza delle biotech	09/03
ETF de la semaine : miser sur le retournement des Biotechs	08/03
Biomarin Pharmaceutical Insider Sold Shares Worth $348,280, According to a Recent SEC Filing	07/03
BioMarin Pharmaceutical Appoints Cristin Hubbard as Chief Commercial Officer	07/03
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer	07/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen BioMarin Pharmaceutical Inc.

Aandelen

BMRN

US09061G1013

Andere talen

Filters